Compare ONCH & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONCH | CATX |
|---|---|---|
| Founded | 2024 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.7M | 262.5M |
| IPO Year | 2025 | 2018 |
| Metric | ONCH | CATX |
|---|---|---|
| Price | $10.37 | $0.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $10.57 |
| AVG Volume (30 Days) | 26.3K | ★ 2.7M |
| Earning Date | 01-01-0001 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.20 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.13 | $1.03 |
| 52 Week High | $10.49 | $6.16 |
| Indicator | ONCH | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 68.22 | 20.74 |
| Support Level | $10.16 | N/A |
| Resistance Level | N/A | $2.40 |
| Average True Range (ATR) | 0.00 | 0.21 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 100.00 | 1.08 |
1RT Acquisition Corp is a blank check company.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.